(Allergan plc)

	AGN latest price $190.3338 (1.33%) ($185.2971 - $190.5715) on Tue. Oct. 9, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.96% (three month average)
RSI	60
Latest Price	$190.3338(1.33%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 0.5% a week on average for past two weeks.
Market Behavior	Value stocks sell-off for large cap. Growth stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XBI(48%)    XLV(48%)    ARKG(47%)    IVW(46%)
Factors Impacting AGN price	AGN will decline at least -0.48% in a week (0% probabilities).   VIXM(-28%)    TLT(-23%)    UUP(-19%)    VXX(-15%)    DIA(-12%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.48% (StdDev 0.96%)
Hourly BBV	0 ()
Intraday Trend	1.3%

5 Day Moving Average	$189.64(0.37%)
10 Day Moving Average	$189.64(0.37%)
20 Day Moving Average	$188.32(1.07%)
To recent high	-0.7%
To recent low	12.3%
Market Cap	$62.753b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed